Key facts
- Clinomic’s last known valuation is $12.0M (Mar 2021).
- It has raised $50.8M; the latest was Later Stage VC ($25.0M) in Apr 2025.
- Notable investors include Bundesministerium für Bildung und Forschung, DeepTech & Climate Fonds, EIT Health, Sana Kliniken, Scale Up.NRW — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Clinomic
- ·The full record, as it builds
Funding rounds
No funding rounds for Clinomic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clinomic
Developer of a medical software platform designed to manage electronic health records systems and analyze patient data. The company's platform leverages artificial intelligence and clinical data to provide clinicians with real-time insights and decision support tools, enabling healthcare providers in intensive care units to optimize treatment plans and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Aachen, Germany
- Founded
- 2019
- Employees
- 75
- Website
- clinomic.ai/
- Ownership
- Privately Held (backing)
Clinomic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clinomic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clinomic in its N-PORT filings yet. We sweep new filings monthly.